By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Baxter International, Inc. 

One Baxter Parkway

Deerfield  Illinois  60015  U.S.A.
Phone: 847-948-2000 Fax: 847-948-3642


Baxter International, Inc. (NYSE:BAX) is a global healthcare company that, through its subsidiaries assists healthcare professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. With 2006 sales of $10.4 billion, and approximately 45,000 employees, Baxter applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

Business Overview:

Baxter is a leading manufacturer of plasma-based and recombinant proteins used to treat hemophilia. Other biopharmaceutical products include plasma-based therapies to treat immune disorders, alpha 1 antitrypsin deficiency and other chronic blood-related conditions; biosurgery products for hemostasis, wound-sealing, and tissue regeneration; and vaccines. Baxter also is a leading manufacturer of manual and automated blood and blood-component separation and collection systems.

Medication Delivery
Baxter is a leading manufacturer of intravenous (IV) solutions and administration sets, premixed drugs and drug reconstitution systems, pre-filled vials and syringes for injectable drugs, electronic infusion pumps, and other products used to deliver fluids and drugs to patients. The company also provides IV nutrition solutions, containers and compounding systems and services; general anesthetic agents and critical care drugs; contract manufacturing services, and drug packaging and formulation technologies.

Baxter is a leading manufacturer of products for peritoneal dialysis (PD), a home therapy for people with end-stage renal disease, or irreversible kidney failure. These products include a range of PD solutions and related supplies to help patients safely perform solution exchanges, as well as automated PD cyclers that perform solution exchanges for patients overnight while they sleep. Baxter also distributes instruments and disposables, including dialyzers, for hemodialysis, generally conducted in a hospital or clinic.

Because of our commitment to research and development, Baxter’s history is rich with medical firsts, from the first commercially manufactured intravenous (IV) solutions to the first portable kidney dialysis machine, plus many more. Baxter continually pursues breakthrough technologies through research facilities around the world, and our investments reflect that commitment.

Key Statistics

Ownership: Public

Web Site: Baxter International
Symbol: BAX



Company News
Baxter International (BAX) Third Quarter 2015 Financial Results Conference Call 10/2/2015 7:35:08 AM
Baxter International (BAX) Appoints Munib Islam To Board; Announces Agreement With Third Point 9/30/2015 10:53:21 AM
Baxter International (BAX) To Present At Morgan Stanley (MST) Global Healthcare Conference 9/15/2015 3:37:40 PM
Baxter International (BAX) To Present At The Morgan Stanley Global Healthcare Conference 9/4/2015 7:36:34 AM
Baxter International (BAX) Gets Ready to Unload $1.45 Billion Baxalta Stake 9/2/2015 5:49:40 AM
Baxter International (BAX) And Water Street Announce FDA Approval Of CEFAZOLIN 2 Gram Premix 8/14/2015 10:28:40 AM
Baxter International (BAX) Comments On Schedule 13D Filing By Third Point 8/6/2015 9:24:57 AM
Hedge Fund Becomes Largest Baxter International (BAX) Holder, Wants Say in Picking New CEO 8/6/2015 7:11:58 AM
Baxter International (BAX) Declares Quarterly Dividend 7/30/2015 1:01:32 PM
Baxter International (BAX) Reports Strong Second Quarter Financial Results Exceeding Guidance 7/30/2015 12:56:44 PM